# Glaxosmithkline PLC ADR Equity

Glaxosmithkline PLC ADR Equity is a security (CUSIP 37733W105) tracked across SEC portfolio filings. 5 institutional managers reported $128K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $3.9M via N-PORT as of 2021-09-30.

## Summary

- Issuer: Glaxosmithkline PLC ADR
- Class: Equity
- CUSIP: 37733W105
- Asset category: EC
- 13F holders: 5
- 13F value: $128K
- 13F period: 2026-06-30
- N-PORT fund positions: 2
- N-PORT value: $3.9M
- N-PORT report: 2021-09-30

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [Cascades Capital Asset Management, LLC](https://search.stillhousedata.com/firm/167102) | GREENSBORO, NC | $104K | 1,888 |
| [Asset Planning,Inc](https://search.stillhousedata.com/firm/111535) | LOS ALAMITOS, CA | $14K | 264 |
| [HORIZON FINANCIAL SERVICES, LLC](https://search.stillhousedata.com/firm/158798) | WINSTON SALEM, NC | $7K | 129 |
| Byrne Asset Management LLC | KINGSTON, NJ | $3K | 56 |
| HUNTINGTON NATIONAL BANK | COLUMBUS, OH | $40 | 1 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Nuveen Tax-Advantaged Total Return Strategy Fund | Nuveen Tax-Advantaged Total Return Strategy Fund | $2.6M | 156.58% |
| Nuveen Diversified Dividend and Income Fund | Nuveen Diversified Dividend and Income Fund | $1.3M | 58.48% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/37733w105.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.